---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-010538"
form_type: "8-K"
ticker: "SKIN"
cik: "0001818093"
company_name: "SkinHealth Systems Inc."
filed_at: "2024-03-12T23:59:59+00:00"
generated_at: "2026-06-04T23:14:17.155853+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# BeautyHealth Q4 net sales $96.8M (-1.3% YoY); full year net loss $100.1M

## Summary
- Full year net sales $398.0M, up 8.8% YoY; Q4 net sales $96.8M, down 1.3% YoY.
- Full year net loss $100.1M (vs $44.2M income in 2022); Q4 net loss $9.4M (vs $6.5M income).
- Full year adjusted EBITDA $24.3M (6.1% margin) vs $46.1M (12.6% margin) in 2022.
- Total delivery systems sold in Q4 1,551 vs 2,067 YoY; active install base grew 24% to 31,446.
- Adjusted gross margin fell to 54.6% in Q4 from 73.6% in prior year; full year 62.8% vs 72.6%.

## SEC filing metadata
- accession: 0001628280-24-010538
- form_type: 8-K
- ticker: SKIN
- cik: 0001818093
- company_name: SkinHealth Systems Inc.
- filed_at: 2024-03-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818093/000162828024010538/0001628280-24-010538-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818093/000162828024010538/skin-20240312.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-010538
- JSON: https://secwatch.observer/filing/0001628280-24-010538.json
- Plain text: https://secwatch.observer/filing/0001628280-24-010538.txt

## Key facts
- Earnings Releases
  SkinHealth Systems Inc. reported the fiscal year ended December 31, 2023 results: revenue $398.0 million, net income $(100.1) million.
  - Period: the fiscal year ended December 31, 2023
  - Revenue: $398.0 million
  - Net income: $(100.1) million
  - Result: reported results
  source text: with its disclosure obligations under Regulation FD. --- EX-99.1 (EX-99.1) --- BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results Delivers net sales of $398 million for the full year and $96.8 million for the fourth quarter driven by growth across international markets Long Beach, Calif., March 12, 2024 – The Beauty Health Company (NASDAQ:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000162828024010538/0001628280-24-010538-index.htm
- Earnings Releases
  SkinHealth Systems Inc. reported the fourth quarter ended December 31, 2023 results: revenue $96.8 million, net income $(9.4) million.
  - Period: the fourth quarter ended December 31, 2023
  - Revenue: $96.8 million
  - Net income: $(9.4) million
  - Result: reported results
  source text: Regulation FD. --- EX-99.1 (EX-99.1) --- BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results Delivers net sales of $398 million for the full year and $96.8 million for the fourth quarter driven by growth across international markets Long Beach, Calif., March 12, 2024 – The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth”), home to
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000162828024010538/0001628280-24-010538-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.